Lynch Brian Joseph
SEC CIK 1776196 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | SVP, GC | 17.7K | — | $7.63M | 11 | 2022-12-23 | 2024-01-23 |
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
Lynch Brian Joseph made no open-market trades at MDGL in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-25 | 2024-01-23 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | A - Grant | $0.00 | +3,639 | 17.7K | +26% | $0 |
| 2024-01-18 | 2024-01-16 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | F - Tax | $243.92 | -949 | 14.1K | -6% | -$231.5K | |
| DM | 2023-12-06 | 2023-12-04+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | M - OptEx | $83.28 | +2,800 | 16.0K | +21% | +$233.2K |
| DM | 2023-12-06 | 2023-12-04+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | S - Sale+OE | $221.89 | -2,800 | 15.0K | -16% | -$621.3K |
| DM | 2023-12-01 | 2023-11-29+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | S - Sale+OE | $201.50 | -7,000 | 15.0K | -32% | -$1.41M |
| DM | 2023-12-01 | 2023-11-29+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | M - OptEx | $73.75 | +7,000 | 19.0K | +58% | +$516.2K |
| 2023-01-18 | 2023-01-16 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| DM | 2023-01-06 | 2023-01-03 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | S - Sale+OE | $282.92 | -13.0K | 100 | -99% | -$3.68M |
| D | 2023-01-06 | 2023-01-03 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | M - OptEx | $91.79 | +13.0K | 13.0K | New | +$1.19M |
| DM | 2022-12-28 | 2022-12-23 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | S - Sale+OE | $274.18 | -7,000 | 6,500 | -52% | -$1.92M |
| D | 2022-12-28 | 2022-12-23 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Lynch Brian Joseph | SVP, GC | M - OptEx | $91.79 | +7,000 | 7,000 | New | +$642.5K |
Purchase Sale Sale after option exercise All abbreviations